Skip to main content
Top
Published in: BMC Medical Genetics 1/2011

Open Access 01-12-2011 | Research article

"Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density"

Authors: María Piedra, María T García-Unzueta, Ana Berja, Blanca Paule, Bernardo A Lavín, Carmen Valero, José A Riancho, José A Amado

Published in: BMC Medical Genetics | Issue 1/2011

Login to get access

Abstract

Background

Primary hyperparathyroidism (PHPT) affects mainly cortical bone. It is thought that parathyroid hormone (PTH) indirectly regulates the activity of osteoclasts by means of the osteoprotegerin/ligand of the receptor activator of nuclear factor-κβ (OPG/RANKL) system. Several studies have confirmed that OPG (osteoprotegerin) and RANKL (ligand of the receptor activator of nuclear factor-κβ) loci are determinants of bone mineral density (BMD) in the general population. The aim of this study is to analyze the relationship between fractures and BMD and the rs3102735 (163 A/G), rs3134070 (245 T/G) and rs2073618 (1181 G/C) SNPs of the OPG and the rs2277438 SNP of the RANKL, in patients with sporadic PHPT.

Methods

We enrolled 298 Caucasian patients with PHPT and 328 healthy volunteers in a cross-sectional study. We analyzed anthropometric data, history of fractures or renal lithiasis, biochemical determinants including markers for bone remodelling, BMD measurements in the lumbar spine, total hip, femoral neck and distal radius, and genotyping for the SNPs to be studied.

Results

Regarding the age of diagnosis, BMI, menopause status, frequency of fractures or renal lithiasis, we found no differences between genotypes in any of the SNPs studied in the PHPT group. Significant lower BMD in the distal radius with similar PTH levels was found in the minor allele homozygotes (GG) compared to heterozygotes and major allele homozygotes in both OPG rs3102735 (163 A/G) and OPG rs3134070 (245 T/G) SNPs in those with PHPT compared to control subjects. We found no differences between genotypes of the OPG rs2073618 (1181 G/C) SNP with regard to BMD in the PHPT subjects. In the evaluation of rs2277438 SNP of the RANKL in PHPT patients, we found a non significant trend towards lower BMD in the 1/3 distal radius and at total hip in the minor allele homocygotes (GG) genotype group versus heterocygotes and major allele homocygotes (AA).

Conclusions

Our study provides the first evaluation of the relationship between SNPs of the OPG/RANK system and sporadic PHPT. Subjects with PHPT and minor homocygote genotype (GG) for the OPG rs3102735 (163 A/G) and OPG rs3134070 (245 T/G) SNPs have lower BMD in the distal radius, and this association does not appear to be mediated by differences in PTH serum levels.
Appendix
Available only for authorised users
Literature
1.
go back to reference Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV, Lindsay R, Clemens TL, Bilezikian JP: Skeletal disease in primary hyperparathyroidism. J Bone Miner Res. 1989, 3: 283-291. Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV, Lindsay R, Clemens TL, Bilezikian JP: Skeletal disease in primary hyperparathyroidism. J Bone Miner Res. 1989, 3: 283-291.
2.
go back to reference Parisien M, Cosman F, Mellish RWE, Schnitzer M, Nieves J, Silverberg SJ, Shane E, Kimmel D, Recker RR, Bilezikian JP, Lindsay R, Dempster DW: Bone structure in postmenopausal hyperparathyroid osteoporotic and normal women. J Bone Miner Res. 1995, 10: 1393-1399.CrossRefPubMed Parisien M, Cosman F, Mellish RWE, Schnitzer M, Nieves J, Silverberg SJ, Shane E, Kimmel D, Recker RR, Bilezikian JP, Lindsay R, Dempster DW: Bone structure in postmenopausal hyperparathyroid osteoporotic and normal women. J Bone Miner Res. 1995, 10: 1393-1399.CrossRefPubMed
3.
go back to reference Dempster DW, Parisien M, Silverberg SJ, Liang XG, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R, Bilezikian JP: On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endoc Metab. 1999, 84: 1562-1566. 10.1210/jc.84.5.1562. Dempster DW, Parisien M, Silverberg SJ, Liang XG, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R, Bilezikian JP: On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endoc Metab. 1999, 84: 1562-1566. 10.1210/jc.84.5.1562.
4.
go back to reference Bollerslev J, Jansson S, Mollerup C, Nordenström J, Lundgren E, Tørring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T: Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endoc Metab. 2007, 92: 1687-1692. 10.1210/jc.2006-1836.CrossRef Bollerslev J, Jansson S, Mollerup C, Nordenström J, Lundgren E, Tørring O, Varhaug JE, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T: Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endoc Metab. 2007, 92: 1687-1692. 10.1210/jc.2006-1836.CrossRef
5.
go back to reference Dempster DW, Müller R, Zhou H, Kohler T, Shane E, Parisien M, Silverberg SJ, Bilezikian JP: Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone. 2007, 41: 19-24. 10.1016/j.bone.2007.03.020.CrossRefPubMedPubMedCentral Dempster DW, Müller R, Zhou H, Kohler T, Shane E, Parisien M, Silverberg SJ, Bilezikian JP: Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone. 2007, 41: 19-24. 10.1016/j.bone.2007.03.020.CrossRefPubMedPubMedCentral
6.
go back to reference Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ: The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endoc Metab. 2008, 93: 3462-3470. 10.1210/jc.2007-1215.CrossRef Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ: The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endoc Metab. 2008, 93: 3462-3470. 10.1210/jc.2007-1215.CrossRef
7.
go back to reference Mosekilde L: Primary hyperparathyroidism and the skeleton. Clin Endocrinol. 2008, 69: 1-19. 10.1111/j.1365-2265.2007.03162.x.CrossRef Mosekilde L: Primary hyperparathyroidism and the skeleton. Clin Endocrinol. 2008, 69: 1-19. 10.1111/j.1365-2265.2007.03162.x.CrossRef
8.
go back to reference Moosgaard B, Christensen SE, Vestergaard P, Heickendorff L, Christiansen P, Mosekilde L: Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin Endocrinol. 2008, 68: 707-715. 10.1111/j.1365-2265.2007.03109.x.CrossRef Moosgaard B, Christensen SE, Vestergaard P, Heickendorff L, Christiansen P, Mosekilde L: Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin Endocrinol. 2008, 68: 707-715. 10.1111/j.1365-2265.2007.03109.x.CrossRef
9.
go back to reference Khan A, Bilezikian J: Primary Hiperparathyroidism: pathophysiology and impact on bone. Can Med Assoc J. 2000, 163: 184-187. Khan A, Bilezikian J: Primary Hiperparathyroidism: pathophysiology and impact on bone. Can Med Assoc J. 2000, 163: 184-187.
10.
go back to reference Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C: Surgery or surveillance for mild asymptomatic prymary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab. 2007, 92: 3114-3121. 10.1210/jc.2007-0219.CrossRefPubMed Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C: Surgery or surveillance for mild asymptomatic prymary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab. 2007, 92: 3114-3121. 10.1210/jc.2007-0219.CrossRefPubMed
11.
go back to reference Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 1998, 95: 3597-3602. 10.1073/pnas.95.7.3597.CrossRefPubMedPubMedCentral Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T: Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 1998, 95: 3597-3602. 10.1073/pnas.95.7.3597.CrossRefPubMedPubMedCentral
12.
go back to reference Richards JB, Rivadeneira F, Intuye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumanduri V, Moorhouse M, van Meurs JB, Hofman A, Pols HA, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukas P, Uitterlinden AG, Spector TD: Bone mineral density, osteoporosis and osteoporotic fractures: a genome-wide association study. Lancet. 2008, 371: 1505-12. 10.1016/S0140-6736(08)60599-1.CrossRefPubMedPubMedCentral Richards JB, Rivadeneira F, Intuye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumanduri V, Moorhouse M, van Meurs JB, Hofman A, Pols HA, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukas P, Uitterlinden AG, Spector TD: Bone mineral density, osteoporosis and osteoporotic fractures: a genome-wide association study. Lancet. 2008, 371: 1505-12. 10.1016/S0140-6736(08)60599-1.CrossRefPubMedPubMedCentral
13.
go back to reference Styrkasdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K: Multiple genetic loci for bone mineral density and fractures. New Engl J Med. 2008, 358: 2355-2365. 10.1056/NEJMoa0801197.CrossRef Styrkasdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K: Multiple genetic loci for bone mineral density and fractures. New Engl J Med. 2008, 358: 2355-2365. 10.1056/NEJMoa0801197.CrossRef
14.
go back to reference Paternoster L, Ohlsson C, Sayers L, Vandenput L, Lorentzon M, Evans DM, Tobias JH: OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon Longitudinal Study of Parents and Children and Gothenburg Osteoporosis and Obesity Determinants cohorts. J Clin Endoc Metab. 2010, 95: 3940-3948. 10.1210/jc.2010-0025.CrossRef Paternoster L, Ohlsson C, Sayers L, Vandenput L, Lorentzon M, Evans DM, Tobias JH: OPG and RANK polymorphisms are both associated with cortical bone mineral density: findings from a metaanalysis of the Avon Longitudinal Study of Parents and Children and Gothenburg Osteoporosis and Obesity Determinants cohorts. J Clin Endoc Metab. 2010, 95: 3940-3948. 10.1210/jc.2010-0025.CrossRef
15.
go back to reference Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF: Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res. 2002, 17: 1245-1255. 10.1359/jbmr.2002.17.7.1245.CrossRefPubMed Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF: Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res. 2002, 17: 1245-1255. 10.1359/jbmr.2002.17.7.1245.CrossRefPubMed
16.
go back to reference Jorgensen HL, Kusk P, Madsen B, Fenger M, Lauritzen JB: Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratio. J Bone Miner Metab. 2004, 22: 132-138. 10.1007/s00774-003-0461-3.CrossRefPubMed Jorgensen HL, Kusk P, Madsen B, Fenger M, Lauritzen JB: Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratio. J Bone Miner Metab. 2004, 22: 132-138. 10.1007/s00774-003-0461-3.CrossRefPubMed
17.
go back to reference Takács I, Lazáry Á, Kósa JP, Kiss J, Balla B, Nagy Z, Bácsi K, Speer G, Lakatos P: Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression. Eur J Endocrinol. 2010, 162: 423-431. 10.1530/EJE-09-0617.CrossRefPubMed Takács I, Lazáry Á, Kósa JP, Kiss J, Balla B, Nagy Z, Bácsi K, Speer G, Lakatos P: Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression. Eur J Endocrinol. 2010, 162: 423-431. 10.1530/EJE-09-0617.CrossRefPubMed
18.
go back to reference Yamada Y, Ando F, Niino N, Shimokata H: Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. Mol Genet Metab. 2003, 80: 344-349. 10.1016/S1096-7192(03)00125-2.CrossRefPubMed Yamada Y, Ando F, Niino N, Shimokata H: Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. Mol Genet Metab. 2003, 80: 344-349. 10.1016/S1096-7192(03)00125-2.CrossRefPubMed
19.
go back to reference Arko B, Prezelj J, Kocijancic A, Komel R, Marc J: Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Maturitas. 2005, 51: 270-279. 10.1016/j.maturitas.2004.08.006.CrossRefPubMed Arko B, Prezelj J, Kocijancic A, Komel R, Marc J: Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Maturitas. 2005, 51: 270-279. 10.1016/j.maturitas.2004.08.006.CrossRefPubMed
20.
go back to reference Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM: Association between osteoprotegerin (OPG), receptor activator of nuclear factor-JB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause. 2007, 14: 913-918. 10.1097/gme.0b013e31802d976f.CrossRefPubMed Kim JG, Kim JH, Kim JY, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM: Association between osteoprotegerin (OPG), receptor activator of nuclear factor-JB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause. 2007, 14: 913-918. 10.1097/gme.0b013e31802d976f.CrossRefPubMed
21.
go back to reference Zhao H, Liu J, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Uitterlinden AG, Chen JL: The influence of Lys3Asn polymorphism in the osteoprotegerin gene of bone mineral density in Chinese postmenopausal women. Osteoporosis Int. 2005, 16: 1519-1524. 10.1007/s00198-005-1865-9.CrossRef Zhao H, Liu J, Ning G, Zhao YJ, Zhang LZ, Sun LH, Xu MY, Uitterlinden AG, Chen JL: The influence of Lys3Asn polymorphism in the osteoprotegerin gene of bone mineral density in Chinese postmenopausal women. Osteoporosis Int. 2005, 16: 1519-1524. 10.1007/s00198-005-1865-9.CrossRef
22.
go back to reference Choi JY, Shin A, Park SK, Chung HW, Cho SI, Shin CS, Kim H, Lee KM, Lee KH, Kang C, Cho DY, Kang D: Genetic Polymorphisms of OPG, RANK, and ESR1, and Bone Mineral Density in Korean Postmenopausal Women. Calcified Tissue Int. 2005, 77: 152-159. 10.1007/s00223-004-0264-0.CrossRef Choi JY, Shin A, Park SK, Chung HW, Cho SI, Shin CS, Kim H, Lee KM, Lee KH, Kang C, Cho DY, Kang D: Genetic Polymorphisms of OPG, RANK, and ESR1, and Bone Mineral Density in Korean Postmenopausal Women. Calcified Tissue Int. 2005, 77: 152-159. 10.1007/s00223-004-0264-0.CrossRef
23.
go back to reference García-Unzueta MT, Riancho JA, Zarrabeitia MT, Sañudo C, Berja A, Valero C, Pesquera C, Paule B, González-Macías J, Amado JA: Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density. Horm Metab Res. 2008, 40: 219-224. 10.1055/s-2008-1046793.CrossRefPubMed García-Unzueta MT, Riancho JA, Zarrabeitia MT, Sañudo C, Berja A, Valero C, Pesquera C, Paule B, González-Macías J, Amado JA: Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density. Horm Metab Res. 2008, 40: 219-224. 10.1055/s-2008-1046793.CrossRefPubMed
24.
go back to reference Moffett SP, Oakley JI, Cauley JA, Lui LY, Ensrud KE, Taylor BC, Hillier TA, Hochberg MC, Li J, Cayabyab S, Lee JM, Peltz G, Cummings SR, Zmuda JM: Study of Osteoporotic Fractures Research Group. Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women. J Clin Endoc Metab. 2008, 93: 2002-2008. 10.1210/jc.2007-1019.CrossRef Moffett SP, Oakley JI, Cauley JA, Lui LY, Ensrud KE, Taylor BC, Hillier TA, Hochberg MC, Li J, Cayabyab S, Lee JM, Peltz G, Cummings SR, Zmuda JM: Study of Osteoporotic Fractures Research Group. Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women. J Clin Endoc Metab. 2008, 93: 2002-2008. 10.1210/jc.2007-1019.CrossRef
25.
go back to reference Ohmori H, Makita Y, Funamizu M, Hirooka K, Hosoi T, Orimo H, Suzuki T, Ikari K, Nakajima T, Inoue I, Hata A: Linkage and association analyses of the OPG gene locus with human osteoporosis. J Hum Genet. 2002, 47: 400-406. 10.1007/s100380200058.CrossRefPubMed Ohmori H, Makita Y, Funamizu M, Hirooka K, Hosoi T, Orimo H, Suzuki T, Ikari K, Nakajima T, Inoue I, Hata A: Linkage and association analyses of the OPG gene locus with human osteoporosis. J Hum Genet. 2002, 47: 400-406. 10.1007/s100380200058.CrossRefPubMed
26.
go back to reference Wynne F, Drummond F, O'Sullivan K, Daly M, Shanahan F, Molloy MG, Quane KA: Investigation of the genetic influence of the OPG, VDR (Fok1) and COLIA1 Sp1 polymorphisms on BMD in the Irish population. Calcified Tissue Int. 2002, 71: 26-35. 10.1007/s00223-001-2081-z.CrossRef Wynne F, Drummond F, O'Sullivan K, Daly M, Shanahan F, Molloy MG, Quane KA: Investigation of the genetic influence of the OPG, VDR (Fok1) and COLIA1 Sp1 polymorphisms on BMD in the Irish population. Calcified Tissue Int. 2002, 71: 26-35. 10.1007/s00223-001-2081-z.CrossRef
27.
go back to reference Ueland T, Bollerslev J, Wilson SG, Dick IM, Islam FM, Mullin BH, Devine A, Prince RL: No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. Bone. 2007, 40: 175-181. 10.1016/j.bone.2006.06.022.CrossRefPubMed Ueland T, Bollerslev J, Wilson SG, Dick IM, Islam FM, Mullin BH, Devine A, Prince RL: No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women. Bone. 2007, 40: 175-181. 10.1016/j.bone.2006.06.022.CrossRefPubMed
28.
go back to reference Jurado S, Nogues L, Agueda L, Garcia-Giralt N, Urreizti R, Yoskovitz G, Pérez-Edo L, Saló G, Carreras R, Mellibovsky L, Balcells S, Grinberg D, Díez-Pérez A: Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. Osteoporosis Int. 2010, 21: 287-296. 10.1007/s00198-009-0956-4.CrossRef Jurado S, Nogues L, Agueda L, Garcia-Giralt N, Urreizti R, Yoskovitz G, Pérez-Edo L, Saló G, Carreras R, Mellibovsky L, Balcells S, Grinberg D, Díez-Pérez A: Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. Osteoporosis Int. 2010, 21: 287-296. 10.1007/s00198-009-0956-4.CrossRef
29.
go back to reference Dong SS, Liu XG, Chen Y, Guo Y, Wang L, Zhao J, Xiong DH, Xu XH, Recker RR, Deng HW: Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. Calcified Tissue Int. 2009, 85: 104-112. 10.1007/s00223-009-9255-5.CrossRef Dong SS, Liu XG, Chen Y, Guo Y, Wang L, Zhao J, Xiong DH, Xu XH, Recker RR, Deng HW: Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. Calcified Tissue Int. 2009, 85: 104-112. 10.1007/s00223-009-9255-5.CrossRef
30.
go back to reference Hsu YH, Niu T, Terwedow HA, Xu X, Feng Y, Li Z, Brain JD, Rosen CJ, Laird N, Xu X: Variation in genes involved in the RANKL/RANK/OPG bone remodelling pathway are associated with bone mineral density at different skeletal sites in men. Hum Genet. 2006, 118: 568-577. 10.1007/s00439-005-0062-4.CrossRefPubMed Hsu YH, Niu T, Terwedow HA, Xu X, Feng Y, Li Z, Brain JD, Rosen CJ, Laird N, Xu X: Variation in genes involved in the RANKL/RANK/OPG bone remodelling pathway are associated with bone mineral density at different skeletal sites in men. Hum Genet. 2006, 118: 568-577. 10.1007/s00439-005-0062-4.CrossRefPubMed
31.
go back to reference Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 15: 263-265.CrossRef Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 15: 263-265.CrossRef
32.
go back to reference Bolland MJ, Grey AB, Gamble G, Reid IR: Association between Primary Hyperparathyroidism and Increased Body Weight: A Meta-Analysis. J Clin Endoc Metab. 2005, 90: 1525-1530.CrossRef Bolland MJ, Grey AB, Gamble G, Reid IR: Association between Primary Hyperparathyroidism and Increased Body Weight: A Meta-Analysis. J Clin Endoc Metab. 2005, 90: 1525-1530.CrossRef
33.
go back to reference Siilin H, Rastad J, Ljunggren Ö, Lundgren E: Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity. J Clin Endoc Metab. 2008, 93: 47-53.CrossRef Siilin H, Rastad J, Ljunggren Ö, Lundgren E: Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity. J Clin Endoc Metab. 2008, 93: 47-53.CrossRef
34.
go back to reference Vignali E, Viccica G, Diacinti D, Cetani F, Cianferotti L, Ambrogini E, Banti C, Del Fiacco R, Bilezikian JP, Pinchera A, Marcocci C: Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endoc Metab. 2009, 94: 2306-2312. 10.1210/jc.2008-2006.CrossRef Vignali E, Viccica G, Diacinti D, Cetani F, Cianferotti L, Ambrogini E, Banti C, Del Fiacco R, Bilezikian JP, Pinchera A, Marcocci C: Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endoc Metab. 2009, 94: 2306-2312. 10.1210/jc.2008-2006.CrossRef
35.
go back to reference Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L: Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol. 2005, 63: 506-513. 10.1111/j.1365-2265.2005.02371.x.CrossRef Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L: Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol. 2005, 63: 506-513. 10.1111/j.1365-2265.2005.02371.x.CrossRef
36.
go back to reference Stilgren LS, Hegedüs LM, Beck-Nielsen H, Abrahamsen B: Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. Calcified Tissue Int. 2003, 73: 210-216. 10.1007/s00223-002-2100-8.CrossRef Stilgren LS, Hegedüs LM, Beck-Nielsen H, Abrahamsen B: Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. Calcified Tissue Int. 2003, 73: 210-216. 10.1007/s00223-002-2100-8.CrossRef
37.
go back to reference Mezquita-Raya P, de la Higuera M, García DF, Alonso G, Ruiz-Requena ME, de Dios Luna J, Escobar-Jiménez F, Muñoz-Torres M: The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. Osteoporosis Int. 2005, 16: 1368-1374. 10.1007/s00198-005-1844-1.CrossRef Mezquita-Raya P, de la Higuera M, García DF, Alonso G, Ruiz-Requena ME, de Dios Luna J, Escobar-Jiménez F, Muñoz-Torres M: The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. Osteoporosis Int. 2005, 16: 1368-1374. 10.1007/s00198-005-1844-1.CrossRef
38.
go back to reference Arko B, Prezelj J, Komel R, Kocijancic A, Hudler P, Marc J: Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. J Clin Endoc Metab. 2002, 87: 4080-4088. 10.1210/jc.2002-020124.CrossRef Arko B, Prezelj J, Komel R, Kocijancic A, Hudler P, Marc J: Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. J Clin Endoc Metab. 2002, 87: 4080-4088. 10.1210/jc.2002-020124.CrossRef
Metadata
Title
"Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density"
Authors
María Piedra
María T García-Unzueta
Ana Berja
Blanca Paule
Bernardo A Lavín
Carmen Valero
José A Riancho
José A Amado
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2011
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-12-168

Other articles of this Issue 1/2011

BMC Medical Genetics 1/2011 Go to the issue